Alternatives to TD Tele-Doc Weight Loss

FDA warning letter #728279 (Jun. 2026), which names tryeden.com. Read live on 2026-08-26, the GLP-1 page prices compounded semaglutide at $99 a month and compounded tirzepatide at $199 — and the asterisk under both figures is the part that changes the math. It reads: price includes medication only, an active Eden Membership is required at $39 for the first month and $99 a month thereafter, and medication is not available without a membership. So this is two line items, not one, and the second one is not next to the number on the page. What Eden does give you is range: brand Zepbound, Ozempic and Mounjaro at $1,399 a month and Wegovy at $1,695, each on its own product page marked In Stock, alongside the compounded lane. It says it serves GLP-1 programs in all fifty states, and its "same price at every dose" policy means titrating up does not raise the medication line. Cancellation is self-serve in the portal, though the Terms want 48 hours' notice before a renewal and make charges non-refundable once an order is fulfilled.

It prices Ozempic and Zepbound at $1,399 and $1,599, which almost nobody here does. The compounded line is “from” $49 — under a dated sale, and billed every four weeks.

NextMeds bundles online care with medication when prescribed, but confirm the total commitment and allow at least 72 hours to cancel before renewal. Our August review linked the brand to Trinity HealthCare Supply, the recipient of an FDA warning letter concerning altRx; today’s Terms do not independently re-establish that ownership relationship.

The insurance-and-brand heavyweight: a WeightWatchers-run membership that routes you toward FDA-approved product and insurance coverage, with a video visit required in some states — the membership fee and the medication bill are two separate charges.

On logistics Hello Alpha is one of the easiest entries on this page: appointment-free online visits, unlimited provider messaging, free shipping, and a women's health platform behind it rather than a single-product weight-loss funnel. On cost it is one of the hardest to plan for. The $79 a month it publishes is the Alpha Plus+ membership, and the medication is billed on top of it — 'insurance or cash pay', with Hello Alpha stating it will work with your plan to find the lowest cost. It prescribes FDA-approved products only, which is its own stated policy, so the menu is the Zepbound and Mounjaro pens and Rybelsus tablets, and no compounded semaglutide exists here at all. That combination has a clear shape: if your employer plan covers a GLP-1, this is one of the few providers on this page built to use that coverage instead of routing around it, and $79 plus a copay may be the cheapest real outcome available to you. If you are paying cash, the total is unknowable in advance, because no cash medication price is published anywhere on the site, and the compounded providers here will be both cheaper and clearer. Hello Alpha is also explicit that a membership does not guarantee a prescription, which is the right thing to say and worth knowing before you pay.

AskRx solves the pricing question most of this page leaves open, and creates a different one. Its care fee is itemized in its own footnote — $90/month physician visit, $10/month fulfilment, $100 total — and the medication is billed separately through its own pharmacy, at cost, with both halves shown at checkout. If you have ever wondered how much of a blended monthly price is the drug and how much is margin, this is the provider that answers it. It is FDA-approved only ('No compounded meds'), so the options are the Wegovy pen, the Wegovy pill, Zepbound in pen or KwikPen form, and Foundayo, the oral tirzepatide. All 50 states, board-certified physicians with obesity-medicine training, unlimited messaging, monthly titration, cancel anytime. Two logistics notes that matter on a workday. First, $100 is a floor: no medication price is published, so your real monthly total is unknown until checkout and depends on coverage. Second — and read this one if scheduling is your constraint — 'video visits available in select states' means the async route is not universal here, so confirm your own state before assuming you can do this without a call.

The only program here that bills insurance, and the hardest to fit around a working week: a scheduled 30-minute video visit is the only way in.

A comprehensive-care shop that puts real numbers on the homepage: read live on 2026-08-26, compounded semaglutide is $160 a month or $130 on a three-month plan, tirzepatide $199 or $163, unchanged since early August. Its FAQ says that single figure covers medication, physician care, support, shipping and all supplies with no membership, and unlimited provider messaging is the thing it sells hardest — message your provider anytime, dose changes at no extra cost. Two answers here are better than most of this roster gives. It serves all fifty states and the District of Columbia. And it tells you exactly where a video visit is required rather than leaving it vague: most states can start without one, but Kansas, Louisiana, Mississippi, New Mexico and West Virginia need a brief video or audio visit first. One thing to pin down before you pay is the period — the plan selector says per month, while the refill schedule on the same page says shipped every 28 days, and thirteen refills a year is not the same bill as twelve.

The posted price is half the bill, and the site says so itself. Read live on 26 August 2026, the weight-loss catalog is ten FDA-approved brand listings — Wegovy as a pill and a pen, Zepbound as a vial and a KwikPen, Ozempic in both forms, Mounjaro, and two new oral tablets in the Ozempic Pill and Foundayo — and every single one carries the same footnote: the figure covers medication only, and a membership at $39 for the first month then $149 a month is required and billed separately. So the $149 Wegovy Pill is really about $298 a month and the $299 Zepbound vial is about $448. That membership is not nothing — 24/7 messaging with licensed providers, monthly care-team follow-ups, a smart scale and named in-house clinicians — but it is $1,788 a year on top of the drug. One oddity to open before you buy: Mounjaro and one of two Zepbound listings are posted at a flat $1,899 a month on the same page as Zepbound vials at $299, and nothing explains the gap. Its FAQ asks whether video visits are required and whether all states are served, but keeps both answers inside collapsed panels, so neither could be verified. It carries two FDA warning letters dated 9 September 2025 over the compounded-semaglutide business it has since left behind entirely.